Extractionless high-performance liquid chromatographic method for the simultaneous determination of piroxicam and 5'-hydroxypiroxicam in human plasma and urine.
A Avgerinos, S Axarlis, J Dragatsis, T Karidas, S Malamataris
Index: J. Chromatogr. B, Biomed. Appl. 673(1) , 142-6, (1995)
Full Text: HTML
Abstract
A simple and rapid (extractionless) high-performance liquid chromatographic method with UV detection, at 330 nm, was developed for the simultaneous determination of piroxicam and its major metabolite, 5'-hydroxypiroxicam, in human plasma and urine. Acidified plasma and alkali-treated urine samples are used and naproxen is added as internal standard. The separation is performed at 40 degrees C on a C18 Spherisorb column with acetonitrile--0.1 M sodium acetate (33:67, v/v, pH 3.3) as mobile phase. The retention time is 2.2 min for 5'-hydroxypiroxicam, 2.6 min for piroxicam and 3.2 min for naproxen. The detection limit is 0.05 micrograms/ml using a 100-microliters loop.
Related Compounds
Related Articles:
[The binding of oxicam derivatives to human serum albumin].
1988-08-01
[Arzneimittelforschung 38(8) , 1089-92, (1988)]
[J. Chromatogr. A. 382 , 382-8, (1986)]
[J. Chromatogr. A. 576(1) , 121-8, (1992)]
1998-08-01
[Analyst 123(8) , 1749-52, (1998)]
1998-07-01
[J. Pharm. Biomed. Anal. 17(3) , 515-24, (1998)]